Microbial Metabolite Trimethylamine N-Oxide Promotes Infection by Escalating Intestinal Inflammation, Epithelial Damage, and Barrier Disruption

Caitlyn B. Smith,Angela Gao,Paloma Bravo,Ashfaqul Alam
DOI: https://doi.org/10.1101/2024.04.10.588895
2024-04-10
Abstract:The interactions between , a critical foodborne cause of gastroenteritis, and the intestinal microbiota during infection are not completely understood. The crosstalk between and its host is impacted by the gut microbiota through mechanisms of competitive exclusion, microbial metabolites, or immune response. To investigate the role of gut microbiota on pathogenesis, we examined campylobacteriosis in the IL10KO mouse model, which was characterized by an increase in the relative abundance of intestinal proteobacteria, , and inflammatory cytokines during infection. We also found a significantly increased abundance of microbial metabolite Trimethylamine N-Oxide (TMAO) in the colonic lumens of IL10KO mice. We further investigated the effects of TMAO on pathogenesis. We determined that senses TMAO as a chemoattractant and the administration of TMAO promotes invasion into Caco-2 monolayers. TMAO also increased the transmigration of across polarized monolayers of Caco-2 cells, decreased TEER, and increased -mediated intestinal barrier damage. Interestingly, TMAO treatment and presence during infection of Caco-2 cells synergistically caused an increased inflammatory cytokine expression, specifically IL-1β and IL-8. These results establish that utilizes microbial metabolite TMAO for increased virulence during infection.
Microbiology
What problem does this paper attempt to address?